Loading...
Loading...
ABSI| Name | Value |
|---|---|
| Revenues | 3.4M |
| Cost of Revenue | 3.5M |
| Gross Profit | -0.1M |
| Operating Expense | 25.0M |
| Operating I/L | -43.0M |
| Other Income/Expense | -19.8M |
| Interest Income | 0.3M |
| Pretax | -41.7M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -41.7M |
Absci Corporation is a drug and target discovery company that provides biologic drug candidates and production cell lines to partners in the United States. The company's integrated drug creation platform streamlines the drug discovery and cell line development processes, allowing for the efficient creation of biologics. By offering these services, Absci Corporation generates revenue through partnerships and collaborations with pharmaceutical and biotechnology companies, leveraging its expertise in biologic drug development and production cell line engineering.
